Definium Therapeutics (Formerly MindMed) is forging a new era in psychiatry by harnessing the full therapeutic potential of psychedelic medicine.

Find the latest Definium Therapeutics, Inc. (DFTX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Jan 12, 2026 · Mind Medicine has altered its state, rebranding as Definium Therapeutics ahead of a series of phase 3 data drops on its lead psychedelic drug candidate. The biotech, which abbreviated …

Jan 12, 2026 · Definium is a clinical-stage biotech focused on developing psychedelic-inspired medicines for psychiatric disorders, including generalized anxiety disorder and major depressive …

2 days ago · DFTX | Complete Definium Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Jan 13, 2026 · NEW YORK – Mind Medicine (MindMed) Inc., a developer of treatments derived from psychedelics for mental health conditions, has changed its name to Definium Therapeutics Inc., a …

6 days ago · A detailed overview of Definium Therapeutics, Inc. (DFTX) stock, including real-time price, chart, key statistics, news, and more.

Feb 2, 2026 · The mission of Definium Therapeutics (formerly MindMed) is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible …

3 days ago · Definium Therapeutics (DFTX) has drawn fresh attention after Jefferies issued a new positive rating and Baird lifted its expectations, both highlighting the clinical potential of DT120, along …

Jan 12, 2026 · Definium is developing innovative, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission …